Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum

Primary (AL) amyloidosis of the gastrointestinal tract is relatively rare, and symptomatic amyloidosis of the stomach is even more seldom. We present the case of a patient who was referred to upper endoscopy because of weight loss, nausea, and vomiting. Large areas of intramucosal hemorrhages were s...

Full description

Bibliographic Details
Main Authors: Reidar Fossmark, Espen Skarsvåg, Harald Aarset, Henrik Hjorth-Hansen, Helge L. Waldum
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Gastrointestinal Medicine
Online Access:http://dx.doi.org/10.1155/2013/525439
id doaj-0fe794de8c0a4836b66adf1ec639d628
record_format Article
spelling doaj-0fe794de8c0a4836b66adf1ec639d6282020-11-24T23:52:55ZengHindawi LimitedCase Reports in Gastrointestinal Medicine2090-65282090-65362013-01-01201310.1155/2013/525439525439Symptomatic Primary (AL) Amyloidosis of the Stomach and DuodenumReidar Fossmark0Espen Skarsvåg1Harald Aarset2Henrik Hjorth-Hansen3Helge L. Waldum4Department of Gastroenterology and Hepatology, St. Olavs Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, NorwayDepartment of Gastroenterology and Hepatology, St. Olavs Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, NorwayDepartment of Pathology and Medical Genetics, St. Olavs Hospital, Erling Skjalgssons Gate 1, 7006 Trondheim, NorwayDepartment of Haematology, St. Olavs Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, NorwayDepartment of Gastroenterology and Hepatology, St. Olavs Hospital, Prinsesse Kristinas Gate 1, 7006 Trondheim, NorwayPrimary (AL) amyloidosis of the gastrointestinal tract is relatively rare, and symptomatic amyloidosis of the stomach is even more seldom. We present the case of a patient who was referred to upper endoscopy because of weight loss, nausea, and vomiting. Large areas of intramucosal hemorrhages were seen, and biopsies resulted in profuse bleeding stopped with endoscopic clips. The biopsies showed amyloid depositions and further workup revealed that the patient also had cardiac and neuropathic involvements. The patient started treatment with dexamethasone, melphalan and bortezomib. After treatment was started the nausea and epigastric discomfort improved, and a reduction in the biochemical markers troponin T, NT-proBNP, and M-component was observed. Gastric amyloidosis is rarely seen at upper endoscopy in patients without a previously established diagnosis, but the unusual endoscopic findings and bleeding tendency after biopsy should be kept in mind by gastroenterologists.http://dx.doi.org/10.1155/2013/525439
collection DOAJ
language English
format Article
sources DOAJ
author Reidar Fossmark
Espen Skarsvåg
Harald Aarset
Henrik Hjorth-Hansen
Helge L. Waldum
spellingShingle Reidar Fossmark
Espen Skarsvåg
Harald Aarset
Henrik Hjorth-Hansen
Helge L. Waldum
Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum
Case Reports in Gastrointestinal Medicine
author_facet Reidar Fossmark
Espen Skarsvåg
Harald Aarset
Henrik Hjorth-Hansen
Helge L. Waldum
author_sort Reidar Fossmark
title Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum
title_short Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum
title_full Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum
title_fullStr Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum
title_full_unstemmed Symptomatic Primary (AL) Amyloidosis of the Stomach and Duodenum
title_sort symptomatic primary (al) amyloidosis of the stomach and duodenum
publisher Hindawi Limited
series Case Reports in Gastrointestinal Medicine
issn 2090-6528
2090-6536
publishDate 2013-01-01
description Primary (AL) amyloidosis of the gastrointestinal tract is relatively rare, and symptomatic amyloidosis of the stomach is even more seldom. We present the case of a patient who was referred to upper endoscopy because of weight loss, nausea, and vomiting. Large areas of intramucosal hemorrhages were seen, and biopsies resulted in profuse bleeding stopped with endoscopic clips. The biopsies showed amyloid depositions and further workup revealed that the patient also had cardiac and neuropathic involvements. The patient started treatment with dexamethasone, melphalan and bortezomib. After treatment was started the nausea and epigastric discomfort improved, and a reduction in the biochemical markers troponin T, NT-proBNP, and M-component was observed. Gastric amyloidosis is rarely seen at upper endoscopy in patients without a previously established diagnosis, but the unusual endoscopic findings and bleeding tendency after biopsy should be kept in mind by gastroenterologists.
url http://dx.doi.org/10.1155/2013/525439
work_keys_str_mv AT reidarfossmark symptomaticprimaryalamyloidosisofthestomachandduodenum
AT espenskarsvag symptomaticprimaryalamyloidosisofthestomachandduodenum
AT haraldaarset symptomaticprimaryalamyloidosisofthestomachandduodenum
AT henrikhjorthhansen symptomaticprimaryalamyloidosisofthestomachandduodenum
AT helgelwaldum symptomaticprimaryalamyloidosisofthestomachandduodenum
_version_ 1725471563833147392